D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model
Abstract Heterozygous mutations in glucocerebrosidase 1 (GBA1) are a major genetic risk factor for Parkinson’s disease and Dementia with Lewy bodies. Mutations in GBA1 leads to GBA1 enzyme deficiency, and GBA1-associated parkinsonism has an earlier age of onset and more progressive parkinsonism. To...
Main Authors: | Donghoon Kim, Heehong Hwang, Seulah Choi, Sang Ho Kwon, Suhyun Lee, Jae Hong Park, SangMin Kim, Han Seok Ko |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40478-018-0538-9 |
Similar Items
-
Impact of Gba2 on neuronopathic Gaucher’s disease and α-synuclein accumulation in medaka (Oryzias latipes)
by: Etsuro Nakanishi, et al.
Published: (2021-05-01) -
The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects
by: Yoo-Mi Kim, et al.
Published: (2020-11-01) -
Glucocerebrosidase and its relevance to Parkinson disease
by: Jenny Do, et al.
Published: (2019-08-01) -
Next-Generation Sequencing Analysis of GBA1: The Challenge of Detecting Complex Recombinant Alleles
by: Elizabeth G. Woo, et al.
Published: (2021-06-01) -
Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
by: Tae-Un Han, et al.
Published: (2020-05-01)